National Bank Of Canada Adaptive Biotechnologies Corp Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $1,440 - $2,400	500 Added 246.31%	703 $2,000
Q2 2022 Jul 28, 2022	SELL	$6.4 - $14.73 $723,200 - $1.66 Million	-113,000 Reduced 99.82%	203 $2,000
Q1 2022 May 05, 2022	BUY	$10.12 - $28.9 $1.14 Million - $3.27 Million	113,000 Added 55665.02%	113,203 $1.57 Million
Q4 2021 Jan 24, 2022	BUY	$25.17 - $36.85 $5,109 - $7,480	203 New	203 $6,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.